70 related articles for article (PubMed ID: 1355483)
1. Multidrug resistance in rat colon carcinoma cell lines CC531, CC531mdr+ and CC531rev.
Gheuens E; van der Heyden S; Elst H; Eggermont A; Van Oosterom A; De Bruijn E
Jpn J Cancer Res; 1993 Nov; 84(11):1201-8. PubMed ID: 7903965
[TBL] [Abstract][Full Text] [Related]
2. The immunogenic properties of drug-resistant murine tumor cells do not correlate with expression of the MDR phenotype.
Killion JJ; Radinsky R; Dong Z; Fishbeck R; Whitworth P; Fidler IJ
Cancer Immunol Immunother; 1993 Jun; 36(6):381-6. PubMed ID: 8098991
[TBL] [Abstract][Full Text] [Related]
3. Further characterization of the human adrenal-derived P-glycoprotein recognized by monoclonal antibody MRK 16 reacting with only human P-glycoprotein.
Sugawara I; Hamada H; Nakahama M; Okamoto S; Tsuruo T; Mori S
Jpn J Cancer Res; 1989 Dec; 80(12):1199-205. PubMed ID: 2576426
[TBL] [Abstract][Full Text] [Related]
4. Stage-specific frequency and prognostic significance of aneuploidy in patients with sporadic colorectal cancer--a meta-analysis and current overview.
Laubert T; Freitag-Wolf S; Linnebacher M; König A; Vollmar B; Habermann JK;
Int J Colorectal Dis; 2015 Aug; 30(8):1015-28. PubMed ID: 26054386
[TBL] [Abstract][Full Text] [Related]
5. Multidrug resistance in cancer chemotherapy.
Patel NH; Rothenberg ML
Invest New Drugs; 1994; 12(1):1-13. PubMed ID: 7960599
[TBL] [Abstract][Full Text] [Related]
6. P-glycoprotein is not expressed in a majority of colorectal carcinomas and is not regulated by mutant p53 in vivo.
De Angelis P; Stokke T; Smedshammer L; Lothe RA; Lehne G; Chen Y; Clausen OP
Br J Cancer; 1995 Aug; 72(2):307-11. PubMed ID: 7640210
[TBL] [Abstract][Full Text] [Related]
7. Genetic aspects of multidrug resistance.
Biedler JL
Cancer; 1992 Sep; 70(6 Suppl):1799-809. PubMed ID: 1355404
[TBL] [Abstract][Full Text] [Related]
8. Human cell lines as models for multidrug resistance in solid tumours.
Clynes M; Heenan M; Hall K
Cytotechnology; 1993; 12(1-3):231-56. PubMed ID: 7765327
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric analysis of multidrug-resistance-associated antigen (P-glycoprotein) and DNA ploidy in human colon cancer.
Danova M; Giordano M; Erba E; Palmeri S; Candiloro V; Riccardi A; Ucci G; Mazzini G; D'Incalci M; Ascari E
J Cancer Res Clin Oncol; 1992; 118(8):575-80. PubMed ID: 1355483
[TBL] [Abstract][Full Text] [Related]
10. Relationships among tenascin expression, DNA ploidy patterns, and multidrug resistance gene product (P-glycoprotein) in human colon carcinoma.
Sugawara I; Hirakoshi J; Kusakabe M; Masunaga A; Itoyama S; Sakakura T
Jpn J Cancer Res; 1993 Jul; 84(7):703-7. PubMed ID: 7690353
[TBL] [Abstract][Full Text] [Related]
11. Modulation of multidrug resistance by verapamil or mdr1 anti-sense oligodeoxynucleotide does not change the high susceptibility to lymphokine-activated killers in mdr-resistant human carcinoma (LoVo) line.
Rivoltini L; Colombo MP; Supino R; Ballinari D; Tsuruo T; Parmiani G
Int J Cancer; 1990 Oct; 46(4):727-32. PubMed ID: 1976601
[TBL] [Abstract][Full Text] [Related]
12. Organ-specific modulation of steady-state mdr gene expression and drug resistance in murine colon cancer cells.
Dong Z; Radinsky R; Fan D; Tsan R; Bucana CD; Wilmanns C; Fidler IJ
J Natl Cancer Inst; 1994 Jun; 86(12):913-20. PubMed ID: 7910854
[TBL] [Abstract][Full Text] [Related]
13. Relationship of P-glycoprotein and carcinoembryonic antigen expression in human colon carcinoma to local invasion, DNA ploidy, and disease relapse.
Sinicrope FA; Hart J; Brasitus TA; Michelassi F; Lee JJ; Safa AR
Cancer; 1994 Dec; 74(11):2908-17. PubMed ID: 7954255
[TBL] [Abstract][Full Text] [Related]
14. Reversal of drug resistance in a human colon cancer xenograft expressing MDR1 complementary DNA by in vivo administration of MRK-16 monoclonal antibody.
Pearson JW; Fogler WE; Volker K; Usui N; Goldenberg SK; Gruys E; Riggs CW; Komschlies K; Wiltrout RH; Tsuruo T
J Natl Cancer Inst; 1991 Oct; 83(19):1386-91. PubMed ID: 1681110
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
